30% Survival Breakthrough
4:30–4:51 · 20s
Dr. Rowan Miller reveals their targeted ‘biological missile’ therapy shrank tumors and raised survival in platinum-resistant ovarian cancer patients by 30%.
4:30–4:51 · 20s
Dr. Rowan Miller reveals their targeted ‘biological missile’ therapy shrank tumors and raised survival in platinum-resistant ovarian cancer patients by 30%.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.